tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Disc Medicine announces feedback from pre-NDA meeting with FDA for bitopertin
PremiumThe FlyDisc Medicine announces feedback from pre-NDA meeting with FDA for bitopertin
2M ago
Disc Medicine initiated with a Buy at Truist
Premium
The Fly
Disc Medicine initiated with a Buy at Truist
2M ago
Buy Rating for Disc Medicine: DISC-0974’s Potential in Myelofibrosis-Related Anemia
Premium
Ratings
Buy Rating for Disc Medicine: DISC-0974’s Potential in Myelofibrosis-Related Anemia
2M ago
Disc Medicine’s Promising Future: Buy Rating Backed by Strong Pipeline and Growth Potential
PremiumRatingsDisc Medicine’s Promising Future: Buy Rating Backed by Strong Pipeline and Growth Potential
2M ago
Promising Potential of Bitopertin in Treating Erythropoietic Protoporphyria Drives Buy Rating for Disc Medicine
Premium
Ratings
Promising Potential of Bitopertin in Treating Erythropoietic Protoporphyria Drives Buy Rating for Disc Medicine
2M ago
Disc Medicine’s Promising Hematology Pipeline and Positive Trial Results Earn Buy Rating
Premium
Ratings
Disc Medicine’s Promising Hematology Pipeline and Positive Trial Results Earn Buy Rating
3M ago
Promising Developments in Disc Medicine’s Portfolio Support Buy Rating
PremiumRatingsPromising Developments in Disc Medicine’s Portfolio Support Buy Rating
3M ago
Disc Medicine presents clinical data updates across portfolio at EHA 2025
Premium
The Fly
Disc Medicine presents clinical data updates across portfolio at EHA 2025
3M ago
Disc Medicine resumed with a Strong Buy at Raymond James
Premium
The Fly
Disc Medicine resumed with a Strong Buy at Raymond James
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100